The Effect of Mindfulness-Based Breathing Exercises in Lung Cancer Patients Undergoing Chemotherapy
Breathing exercises to ease chemo side effects in lung cancer patients
Plain English Summary
The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy is a Not Applicable clinical trial sponsored by Firat University studying Lung Cancer. This trial tests if mindfulness breathing exercises can help lung cancer patients undergoing chemotherapy feel less short of breath and improve their overall well-being. It is for adult lung cancer patients who are receiving chemotherapy. Participants will either do guided breathing exercises for 8 weeks or receive standard care. The alternative is standard medical care without the specific breathing exercises. The trial aims to enroll 60 participants.
Official Summary
This research is designed to determine the effect of mindfulness-based breathing exercises on dyspnea, symptom control, and quality of life in lung cancer patients undergoing chemotherapy. Lung cancer is a disease with a high mortality rate and a heavy symptom burden, and symptoms such as dyspnea, fatigue, pain, anxiety, and sleep problems are frequently observed during chemotherapy. Dyspnea, in particular, is one of the main symptoms that has both physical and emotional dimensions and significantly negatively affects patients' daily living activities, adherence to treatment, and quality of life. Therefore, integrating non-pharmacological and complementary nursing interventions into the care process in addition to pharmacological approaches is important. Mindfulness-based breathing exercises are a structured application that aims to regulate the respiratory rhythm, increase relaxation, and reduce symptom perception by enabling the individual to focus on their breath and bodily sensations without judgment. The research will be conducted using a pre-test-post-test control group experimental design. The study will be carried out with lung cancer patients receiving chemotherapy at Gazi Yaşargil Training and Research Hospital between April 2026 and September 2026. The study sample will consist of a total of 60 patients (30 experimental, 30 control) who meet the inclusion criteria and voluntarily agree to participate. Randomization will be used to determine the groups. Patients in the intervention group will receive a mindfulness-based breathing exercise program for eight weeks. The first four weeks will consist of 20-30 minute face-to-face individual training sessions once a week, followed by four weeks of 15-20 minute exercises at home twice a week. The control group will receive no intervention other than routine care. Data will be collected before and eight weeks after the intervention using a Personal Information Form, the Edmonton Symptom Assessment Scale, the EORTC
Who Can Participate
Here is what you need to know about eligibility for this trial. Adults over 18 years old who can communicate well and do not have a psychiatric condition can join. Patients must have completed at least 4 chemotherapy courses and have a physical condition that allows for exercise. Those with communication issues, existing psychiatric problems, or who already do any form of exercise will not be included. Patients in Phase 4 studies are also excluded. This trial is studying Lung Cancer, so participants generally need a confirmed diagnosis.
What They're Measuring
The primary outcomes measure how much the breathing exercises reduce shortness of breath, improve symptom control, and enhance overall quality of life for patients after 8 weeks. The specific primary outcome measures are: Edmonton Symptom Assessment Scale: (8 week); EORTC QLQ-C 30 Quality of Life Scale ( (8 week); DYSPNEA-12 TR SCALE (8 week). These endpoints are how researchers determine whether the treatment is effective and will form the basis of any future regulatory submissions.
About This Phase
This study does not have a traditional clinical phase designation. It may be an observational study that follows patients without intervening in their care, an expanded access or compassionate use program, or other non-interventional research. These studies contribute valuable data about disease progression, treatment patterns, and patient outcomes.
Why This Trial Matters
This trial addresses the significant symptom burden, like shortness of breath, experienced by lung cancer patients during chemotherapy, aiming to improve their quality of life with a non-drug approach This research targets Lung Cancer, where improved treatment options are needed.
Investor Insight
This trial explores a low-cost, non-pharmacological intervention for a large patient population, potentially offering a complementary approach to standard care and indicating a focus on supportive car
Is This Trial Right for Me?
Ask your doctor if this breathing exercise program is suitable for your specific condition and if it might interfere with your chemotherapy. Participation involves attending weekly training sessions for the first month and then practicing exercises at home twice a week for the following month. You will complete questionnaires about your symptoms and quality of life before and after the 8-week program. The trial is being conducted at 1 site. Always discuss clinical trial participation with your healthcare provider before making any decisions. This information is for educational purposes only and is not medical advice.
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.
Study Design
- Study Type: INTERVENTIONAL
- Allocation: RANDOMIZED
- Model: PARALLEL
- Masking: SINGLE
- Enrollment: 60 participants
Interventions
- BEHAVIORAL: Mindfulness-Based Breathing Exercises — Mindfulness-Based Breathing Exercises
Primary Outcomes
- Edmonton Symptom Assessment Scale: (8 week)
- EORTC QLQ-C 30 Quality of Life Scale ( (8 week)
- DYSPNEA-12 TR SCALE (8 week)
Full Eligibility Criteria
Inclusion Criteria: * Being over 18 years of age * Being able to communicate adequately * Not having a psychiatric problem * Those whose physical condition preventing them from exercising has been determined by a physician * Patients who have completed at least 4 courses Exclusion Criteria: * Individuals with communication problems * Individuals with psychiatric problems * Patients who engage in any kind of exercise * Will not be included in Phase 4 studies
Trial Locations
- Fırat university, Elâzığ, Center, Turkey (Türkiye)
Frequently Asked Questions
What is clinical trial NCT07520799?
NCT07520799 is a Not Applicable INTERVENTIONAL study titled "The Effect of Mindfulness-Based Breathing Exercises on Dyspnea, Symptom Control, and Quality of Life in Lung Cancer Patients Undergoing Chemotherapy." It is currently not yet recruiting and is sponsored by Firat University. The trial targets enrollment of 60 participants.
What conditions does NCT07520799 study?
This trial investigates treatments for Lung Cancer. The primary condition under study is Lung Cancer.
What treatments are being tested in NCT07520799?
The interventions being studied include: Mindfulness-Based Breathing Exercises (BEHAVIORAL). Mindfulness-Based Breathing Exercises
What does Not Applicable mean for NCT07520799?
This study does not have a defined clinical phase. It may be an observational study, expanded access program, or other non-interventional research.
What is the current status of NCT07520799?
This trial is currently "Not Yet Recruiting." It started on 2026-05-01. The estimated completion date is 2026-11-01.
Who is sponsoring NCT07520799?
NCT07520799 is sponsored by Firat University. The sponsor is responsible for funding, designing, and overseeing the clinical trial.
How many people can participate in NCT07520799?
The trial aims to enroll 60 participants. The trial has not yet started recruiting.
How is NCT07520799 designed?
This is a interventional study, uses randomized allocation, follows a parallel design, employs single masking. Masking means some participants and/or investigators do not know which treatment group a participant is in, which helps reduce bias.
What are the primary outcomes being measured in NCT07520799?
The primary outcome measures are: Edmonton Symptom Assessment Scale: (8 week); EORTC QLQ-C 30 Quality of Life Scale ( (8 week); DYSPNEA-12 TR SCALE (8 week). These are the main endpoints researchers use to determine whether the treatment is effective.
Where is NCT07520799 being conducted?
This trial is being conducted at 1 site, including Elâzığ, Center (Turkey (Türkiye)).
Where can I find official information about NCT07520799?
The official record for NCT07520799 is available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT07520799. This government database provides the most up-to-date and detailed information about the trial.
What is NCT07520799 testing in simple terms?
This trial tests if mindfulness breathing exercises can help lung cancer patients undergoing chemotherapy feel less short of breath and improve their overall well-being. It is for adult lung cancer patients who are receiving chemotherapy.
Why is this trial significant?
This trial addresses the significant symptom burden, like shortness of breath, experienced by lung cancer patients during chemotherapy, aiming to improve their quality of life with a non-drug approach
What are the potential risks of participating in NCT07520799?
The main risks are minimal and related to the exercises themselves, such as temporary fatigue or discomfort. There is a small chance that the exercises might not be effective for everyone. Potential side effects are generally mild and may include mild dizziness or lightheadedness during breathing exercises. As with any clinical trial, participants are closely monitored and can withdraw at any time.
Should I consider participating in NCT07520799?
Ask your doctor if this breathing exercise program is suitable for your specific condition and if it might interfere with your chemotherapy. Participation involves attending weekly training sessions for the first month and then practicing exercises at home twice a week for the following month. You will complete questionnaires about your symptoms and quality of life before and after the 8-week program. Always discuss clinical trial participation with your healthcare provider to determine if it is appropriate for your specific situation.
What does NCT07520799 signal from an investment perspective?
This trial explores a low-cost, non-pharmacological intervention for a large patient population, potentially offering a complementary approach to standard care and indicating a focus on supportive car This is a Not Applicable trial, which is in early development stages.
What happens if the treatment in this trial doesn't work?
Participants will either do guided breathing exercises for 8 weeks or receive standard care. Participants in clinical trials always have the right to withdraw and pursue alternative treatments. The study team will help transition patients to other available options.
Related Conditions
More Lung Cancer Trials
This analysis is AI-generated and does not constitute medical advice. Always consult your healthcare provider before making decisions about clinical trial participation.